PMC3032250_01
At presentation, right eye color fundus photograph (A) reveals a punched-out pigmented lesion with well-demarcated borders at the macula suggestive of a healed toxoplasma scar. Fluorescein angiography (B) reveals staining of the retinal scar. Optical coherence tomography reveals retinal atrophy corresponding to the lesion (C)
IJO-59-62-g001.jpg
PMC3032250_01_IJO-59-62-g001.jpg
F0001
Fundus evaluation of the right eye showed the presence of a punched-out pigmented lesion with well-demarcated borders at the macula that was suggestive of a healed toxoplasma lesion [Fig. 1A]. Clinical findings were confirmed on fluorescein angiography [Fig. 1B] and Optical coherence tomography [Fig. 1C].
At presentation, left eye color fundus photograph (A) reveals a pigmented lesion at the macula along with a choroidal neovascular membrane, adjacent subretinal hemorrhage and fluid medial to the pigmented scar. Fluorescein angiography (B, C) reveals an active, subfoveal classic choroidal neovascular membrane with profuse leakage. Blocked choroidal fluorescence due to the overlying hemorrhage is also noted. Optical coherence tomography reveals subfoveal choroidal neovascular membrane and subretinal fluid adjacent to a subretinal scar
IJO-59-62-g002.jpg
PMC3032250_01_IJO-59-62-g002.jpg
F0002
Left eye examination not only showed a punched-out pigmented lesion at the macula but also a choroidal neovascular membrane with adjacent subretinal fluid and hemorrhage just medial to the pigmented scar [Fig. 2A]. Blocked choroidal fluorescence due to the overlying hemorrhage was also noted [Fig. 2B]. OCT revealed subfoveal choroidal neovascular membrane (CNVM) and subretinal fluid adjacent to a subretinal scar [Fig. 2C].
At 8 months of follow-up, color fundus photograph (A) reveals a regressed choroidal neovascular membrane. Optical coherence tomography reveals (B) a high reflective subfoveal scar
IJO-59-62-g003.jpg
PMC3032250_01_IJO-59-62-g003.jpg
F0003
N6 and the fundus remained stable up to the eighth month of follow-up [Fig. 3]. No adverse ocular or systemic event related to the treatment procedure was encountered.